Bernhard Hermann Heinrich Breier

Title: Bernhard Hermann Heinrich Breier: Innovator in Immunogenic Detection

Introduction

Bernhard Hermann Heinrich Breier is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of immunology, particularly in the detection of weakly immunogenic analytes. His work has implications for both clinical and research applications.

Latest Patents

Breier holds a patent for "Methods for detecting weakly immunogenic analytes." This patent describes how GPE antibodies recognize GPE with high specificity. When utilized in a radioimmunoassay, these antibodies reliably measure the concentration of GPE. Furthermore, they may be employed to extend the half-life of GPE both in vivo and in vitro, as well as in methods of purifying the GPE receptor. Two methods of rpHPLC accurately revolve GPE based on its hydrophobicity. He has 1 patent to his name.

Career Highlights

Breier is associated with Neuren Pharmaceuticals Limited, where he applies his expertise in immunology to advance the company's research and development efforts. His innovative approaches have contributed to the company's mission of improving health outcomes through scientific advancements.

Collaborations

Breier has worked alongside notable colleagues such as David Charles Batchelor and Gregory Brian Thomas. Their collaborative efforts have further enhanced the research capabilities within their field.

Conclusion

Bernhard Hermann Heinrich Breier is a distinguished inventor whose work in immunogenic detection has paved the way for advancements in medical diagnostics. His contributions continue to influence the field and improve methodologies in immunology.